These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31438950)

  • 21. Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report.
    Lek D; Callery JJ; Nguon C; Debackere M; Sovannaroth S; Tripura R; Wojnarski M; Piola P; Khean ST; Manion K; Nguon S; Kunkel A; Vernaeve L; Peto TJ; Dantzer E; Davoeung C; Etienne W; Dondorp AM; Tuseo L; von Seidlein L; Guintran JO
    Malar J; 2020 Apr; 19(1):151. PubMed ID: 32293452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study.
    Brady OJ; Slater HC; Pemberton-Ross P; Wenger E; Maude RJ; Ghani AC; Penny MA; Gerardin J; White LJ; Chitnis N; Aguas R; Hay SI; Smith DL; Stuckey EM; Okiro EA; Smith TA; Okell LC
    Lancet Glob Health; 2017 Jul; 5(7):e680-e687. PubMed ID: 28566213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria.
    Abdul-Ghani R; Mahdy MA; Beier JC; Basco LK
    Infect Dis Poverty; 2017 Feb; 6(1):12. PubMed ID: 28166813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.
    Finn TP; Yukich JO; Bennett A; Porter TR; Lungu C; Hamainza B; Chizema Kawesha E; Conner RO; Silumbe K; Steketee RW; Miller JM; Keating J; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):19-27. PubMed ID: 32618251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.
    Stuckey EM; Miller JM; Littrell M; Chitnis N; Steketee R
    Malar J; 2016 Mar; 15():148. PubMed ID: 26957364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reviewing South Africa's malaria elimination strategy (2012-2018): progress, challenges and priorities.
    Raman J; Morris N; Frean J; Brooke B; Blumberg L; Kruger P; Mabusa A; Raswiswi E; Shandukani B; Misani E; Groepe MA; Moonasar D
    Malar J; 2016 Aug; 15(1):438. PubMed ID: 27567642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria elimination: Using past and present experience to make malaria-free India by 2030.
    Lal AA; Rajvanshi H; Jayswar H; Das A; Bharti PK
    J Vector Borne Dis; 2019; 56(1):60-65. PubMed ID: 31070168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. malERA: An updated research agenda for combination interventions and modelling in malaria elimination and eradication.
    malERA Refresh Consultative Panel on Combination Interventions and Modelling
    PLoS Med; 2017 Nov; 14(11):e1002453. PubMed ID: 29190295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR.
    Adhikari B; Phommasone K; Pongvongsa T; Kommarasy P; Soundala X; Henriques G; White NJ; Day NPJ; Dondorp AM; von Seidlein L; Cheah PY; Pell C; Mayxay M
    Malar J; 2017 Oct; 16(1):424. PubMed ID: 29061133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parasite Removal for Malaria Elimination in Costa Rica.
    Marín Rodríguez R; Chaves LF
    Trends Parasitol; 2019 Aug; 35(8):585-588. PubMed ID: 31129039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.
    Kajeechiwa L; Thwin MM; Shee PW; Yee NL; Elvina E; Peapah P; Kyawt K; Oo PT; PoWah W; Min JR; Wiladphaingern J; von Seidlein L; Nosten S; Nosten F
    Malar J; 2016 Sep; 15(1):494. PubMed ID: 27677694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malaria elimination in India-The way forward.
    Ghosh SK; Rahi M
    J Vector Borne Dis; 2019; 56(1):32-40. PubMed ID: 31070163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From malaria control to elimination within a decade: lessons learned from Timor Leste, a newly independent country.
    Manel Yapabandara AMG; do Rosario de Fatima Mota M; Sarmento R; Bosco JD; Wickremasinghe R
    Malar J; 2020 Mar; 19(1):104. PubMed ID: 32127001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar.
    Ali AS; Thawer NG; Khatib B; Amier HH; Shija J; Msellem M; Al-Mafazy AW; Garimo IA; Mkali H; Ramsan MM; Kafuko JM; Paxton LA; Reithinger R; Ngondi JM
    Malar J; 2017 Aug; 16(1):332. PubMed ID: 28807035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospects and strategies for malaria elimination in the Greater Mekong Sub-region: a qualitative study.
    Kaehler N; Adhikari B; Cheah PY; von Seidlein L; Day NPJ; Paris DH; Tanner M; Pell C
    Malar J; 2019 Jun; 18(1):203. PubMed ID: 31221145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar.
    Kyaw SS; Delmas G; Drake TL; Celhay O; Pan-Ngum W; Pukrittayakamee S; Lubell Y; Aguas RJ; Maude RJ; White LJ; Nosten F
    BMC Public Health; 2021 Apr; 21(1):826. PubMed ID: 33926399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar.
    Landier J; Kajeechiwa L; Thwin MM; Parker DM; Chaumeau V; Wiladphaingern J; Imwong M; Miotto O; Patumrat K; Duanguppama J; Cerqueira D; Malleret B; Rénia L; Nosten S; von Seidlein L; Ling C; Proux S; Corbel V; Simpson JA; Dondorp AM; White NJ; Nosten FH
    Wellcome Open Res; 2017; 2():81. PubMed ID: 29062913
    [No Abstract]   [Full Text] [Related]  

  • 38. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos).
    Adhikari B; Phommasone K; Kommarasy P; Soundala X; Souvanthong P; Pongvongsa T; Henriques G; Newton PN; White NJ; Day NPJ; Dondorp AM; von Seidlein L; Mayxay M; Cheah PY; Pell C
    Malar J; 2018 Jan; 17(1):15. PubMed ID: 29316932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reflections on a Community Engagement Strategy for Mass Antimalarial Drug Administration in Cambodia.
    Peto TJ; Tripura R; Davoeung C; Nguon C; Nou S; Heng C; Kunthea P; Adhikari B; Lim R; James N; Pell C; Cheah PY
    Am J Trop Med Hyg; 2018 Jan; 98(1):100-104. PubMed ID: 29165227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Sinclair D; Gogtay N; Brand F; Olliaro P
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008492. PubMed ID: 21735431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.